Surviving life-threatening MDMA (3,4-methylenedioxymethamphetamine, ecstasy) toxicity caused by ritonavir (RTV)
- 30 March 2012
- journal article
- other
- Published by Springer Nature in Intensive Care Medicine
- Vol. 38 (7) , 1239-1240
Abstract
No abstract availableKeywords
This publication has 5 references indexed in Scilit:
- Sex Differences in 3,4-Methylenedioxymethamphetamine (MDMA; Ecstasy)-Induced Cytochrome P450 2D6 Inhibition in HumansClinical Pharmacokinetics, 2011
- The Consequences of 3,4-Methylenedioxymethamphetamine Induced CYP2D6 Inhibition in HumansJournal of Clinical Psychopharmacology, 2008
- Non‐linear pharmacokinetics of MDMA (‘ecstasy’) in humansBritish Journal of Clinical Pharmacology, 2000
- Life-Threatening Interactions Between HIV-1 Protease Inhibitors and the Illicit Drugs MDMA and γ-HydroxybutyrateArchives of internal medicine (1960), 1999
- Fatal interaction between ritonavir and MDMAThe Lancet, 1998